Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors
Qian Dong(Chinese Academy of Sciences), Wei Huang(Chinese Academy of Sciences), Mengya Tong(Chinese Academy of Sciences), Likun Gong, Shanhua Fang(Chinese Academy of Sciences), Xiaolu Yu(Chinese Academy of Sciences), Yongliang Tong(Shanghai Medical College of Fudan University), Liguang Lou(Shanghai Institute of Materia Medica), Hu Zhou, Jiwei Ao(Chinese Academy of Sciences), Lei Wang(Shanghai Jiao Tong University), Junjie Liu(Chinese Academy of Sciences), Yubo Tang(Sun Yat-sen University), Yongzhuo Huang(Chinese Academy of Sciences), Long Li(Chinese Academy of Sciences), Dongliang Guan(Yantai University)
Cited by 9
Related Papers
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity <i>in vitro</i> and <i>in vivo</i>
|Cancer Science|2011|519
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
|Cancer Science|2018|368
Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy
|Chemical Science|2018|248